14. E3 Ring Finger Ubiquitin ligases: Structure and Drug Design
14. C.T. Chasapis, G.A. Spyroulias. E3 Ring Finger Ubiquitin ligases: Structure and Drug Design. Curr. Pharm. Design 31, 3716-3731 (2009).
14. C.T. Chasapis, G.A. Spyroulias. E3 Ring Finger Ubiquitin ligases: Structure and Drug Design. Curr. Pharm. Design 31, 3716-3731 (2009).
13. S.-S.M. Vamvakas, L. Leondiadis, G. Pairas, E. Manessi-Zoupa, G.A. Spyroulias, P. Cordopatis. Folding in Solution of the C – Catalytic Protein Fragment of Angiotensin Converting Enzyme. J. Pept. Sci. 15, 504-510 (2009). 10.1002/psc.1151
12. G.A. Dalkas, A. Papakyriakou, A. Vlamis-Gardikas, G.A. Spyroulias. Insights into the anthrax lethal factor-substrate interaction and selectivity using docking and molecular dynamics simulations. Protein Science 18, 1774-1785 (2009). 10.1002/pro.169
11. P.A. Galanakis, N.G. Kandias, A. Rizos, D. Morikis, E. Krambovitis, G.A. Spyroulias. NMR evidence of charge-dependent interaction between various PND V3 and CCR5 N-terminal peptides. Biopolymers – Peptide Science 92, 94-109 (2009). 10.1002/bip.21127
10. N.G. Kandias, C.T. Chasapis, V. Episkopou, D. Bentrop, G.A. Spyroulias. High yield expression, and NMR characterization of Arkadia E3 Ubiquitin Ligase RING-H2 finger domain. BBRC 378, 498-502 (2009). 10.1016/j.bbrc.2008.11.055
9. L. A. Abriata, L. Banci, I. Bertini, S. Ciofi-Baffoni, P. Gkazonis, G.A. Spyroulias, A.J. Vila, S. Wang. Mechanism of CuA assembly. Nature Chemical Biology 4, 599-601 (2008). 10.1038/nchembio.110
8. Z. Zhou, A. Pyriochou, A. Kotanidou, G.A. Dalkas, M. van Eickels, G.A. Spyroulias, C. Roussos A. Papapetropoulos. Soluble guanylyl cyclase (sGC) activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress. American Journal of Physiology – Heart & Circulatory Physiology 295, Η1763-1771 (2008).10.1152/ajpheart.51.2008
7. M. Chondrou, A.D. Papanastasiou, G.A. Spyroulias, I.K. Zarkadis. Three isoforms of Complement Properdin Factor P in trout. Cloning, Expression, Gene Organization and Constrained Modeling. Dev. Comp. Immunol. 12, 1454-1466 (2008). 10.1016/j.dci.2008.06.010
6. G. Dalkas, A.Papakyriakou, A. Vlamis-Gardikas, G.A. Spyroulias. Low molecular weight inhibitors of the protease Anthrax Lethal Factor. Mini Reviews in Medicinal Chemistry 8, 290-306 (2008). 10.2174/138955708783744083
5. M. A. Fousteris,A. Papakyriakou,A. Koutsourea, M. Manioudaki, E. Lampropoulou, E. Papadimitriou,G.A. Spyroulias, S.S. Nikolaropoulos. Pyrrolo[2,3-a]carbazoles as potential CDK1 inhibitors. Synthesis, preliminary biological evaluation and binding mode through docking simulations. J. Med. Chem 51, 1048-1052 (2008).
4. Z. Spyranti, G.A. Dalkas, G.A. Spyroulias, E.D. Matzourani, T. Mavromoustakos, I Friligou, T. Tselios. Putative bioactive conformations of amide linked cyclic myelin basic protein peptide analogues associated with experimental autoimmune encephalomyelitis. J. Med. Chem 50, 6039-6047 (2007). 10.1021/jm070770m
3. A. Papakyriakou, G.A. Spyroulias, E. Sturrock, E. Manessi-Zoupa, P. Cordopatis. Simulated Interactions between Angiotensin-Converting Enzyme and Substrate Gonadotropin-Releasing Hormone: Novel Insights into Domain-Selectivity. Biochemistry ACS 46, 8753-8765 (2007).
2. I. Bertini, I.C. Felli, L. Gonelli, R. Pierattelli, Z. Spyranti, G.A. Spyroulias. Mapping protein-protein interaction by 13C-detected heteronuclear NMR spectroscopy. J. Biomol. NMR 36, 111-122 (2006).
1. L. Banci, I. Bertini, S. Ciofi-Baffoni, N.G. Kandias, G.A. Spyroulias, N.J. Robinson, M. Vanarotti, X.-C. Su. The delivery of copper for thylakoid import observed by NMR. Proc. Natl Acad Sci. USA 103, 8320-8325 (2006).